Raia Drogasil S.A.
RADLY
$3.62
-$0.07-1.90%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 27.25% | 29.78% | 14.83% | 2.83% | -13.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.25% | 29.78% | 14.83% | 2.83% | -13.82% |
| Cost of Revenue | 24.17% | 30.17% | 15.33% | 3.88% | -15.30% |
| Gross Profit | 34.29% | 28.86% | 13.65% | 0.40% | -10.25% |
| SG&A Expenses | 29.47% | 23.65% | 12.76% | 0.63% | -6.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 918.32% | -- | -- | -88.52% | -3,778.31% |
| Total Operating Expenses | 28.42% | 28.49% | 14.69% | 2.98% | -13.28% |
| Operating Income | 5.94% | 53.17% | 16.88% | 0.66% | -22.73% |
| Income Before Tax | -14.44% | 16.30% | 25.77% | -11.57% | -50.03% |
| Income Tax Expenses | -198.68% | 120.08% | -17.07% | -82.10% | -77.42% |
| Earnings from Continuing Operations | 15.55% | -10.22% | 38.63% | 7.15% | -37.74% |
| Earnings from Discontinued Operations | -42.70% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 12,761.84% | -91.34% | -302.91% | 82.86% |
| Net Income | 8.24% | -5.81% | 37.98% | 5.31% | -26.17% |
| EBIT | 5.94% | 53.17% | 16.88% | 0.66% | -22.73% |
| EBITDA | 10.67% | 54.64% | 14.61% | 2.15% | -18.84% |
| EPS Basic | 10.18% | 2.53% | 38.16% | 83.64% | -26.11% |
| Normalized Basic EPS | -24.19% | 39.71% | 7.58% | 49.41% | -38.92% |
| EPS Diluted | 7.83% | 2.25% | 37.82% | 82.71% | -25.56% |
| Normalized Diluted EPS | -26.61% | 39.22% | 7.22% | 48.24% | -38.31% |
| Average Basic Shares Outstanding | -1.89% | -7.96% | -0.10% | -42.57% | -0.15% |
| Average Diluted Shares Outstanding | 0.33% | -7.72% | 0.11% | -42.26% | -0.80% |
| Dividend Per Share | -- | -- | -34.80% | -- | -- |
| Payout Ratio | 3.96% | 0.68% | -0.95% | 0.13% | -0.40% |